Avidity Partners Management LP Immunic, Inc. Transaction History
Avidity Partners Management LP
- $194 Million
- Q3 2025
A detailed history of Avidity Partners Management LP transactions in Immunic, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 4,699,411 shares of IMUX stock, worth $3.52 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
4,699,411
Previous 5,615,811
16.32%
Holding current value
$3.52 Million
Previous $3.93 Million
1.6%
% of portfolio
2.06%
Previous 1.06%
Shares
6 transactions
Others Institutions Holding IMUX
# of Institutions
68Shares Held
42.5MCall Options Held
128KPut Options Held
90.7K-
Abrdn PLC8.24MShares$6.18 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.74 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.26 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.1MShares$2.33 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.58 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $22.9M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...